Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

medical research Press Releases

  + XML/RSS  



By Xhale, Inc.
Xhale Awarded NIH/NIMH SBIR Grant for Monitoring Microbicide Gel Use

By Cures Within Reach
Cures Within Reach is pleased to name Illinois Governor Pat Quinn as honorary chair of the 2nd Bioscience Awards Midwest event on June 17, 2014, celebrating patient impact through science, philanthropy and business.

By Vattikuti Foundation
Transplant Project is the “First” to Use IDEAL* Research Standards to Protect Patients

By Cures Within Reach
Cures Within Reach (Cures), a non-profit dedicated to medical repurposing research, will be represented by Dr. Bruce Bloom and Dr. E. Mitchell Seymour on the Editorial Board of a new journal entitled “Drug Repurposing, Rescue, and Repositioning."

By Cures Within Reach
Cures Within Reach is pleased to announce that Dr. Norbert G. Riedel will receive its Patient Impact Legacy Award at its Midwest BioScience Industry Gala on the evening of June 17th, 2014, in downtown Chicago.

By Arrowhead Publishers
The 4th Annual Traumatic Brain Injury is pleased to announce that Andrew Maas, MD, Ph.D., Professor and Chairman at Antwerp University Hospital and University of Antwerp will return for the 2014 conference.

By Cures Within Reach
Cures Within Reach is partnering with BioMotiv to drive repurposing research toward patient impact, with initial focus on therapies for Lung Cancer.

By Cures Within Reach
The innovative medical research philanthropy Cures Within Reach has announced a marketing partnership with PatientsLikeMe to work together to improve patient lives.

By Discovery Clinical Trials
San Antonio Company Ranks 206th Among Nation’s Health Companies on 2013 List

By Cures Within Reach
Some of the most prominent leaders in bioscience and related industries will gather at the Standard Club in Chicago on Thursday, June 13, to celebrate the growth of the bioscience industry in the Midwest.

By Cures Within Reach
Understanding Drug Development will be the second webcast in the RARE Webinar Series providing relevant information to patients and caregivers battling rare diseases, which are defined as diseases that affect fewer than 200,000 people in the US and...

By Discovery Clinical Trials
South Texas Native Moves Up from Vice President to COO of Discovery Clinical Trials and Synergyst Research Group

By Absolutely PR
Fitzsimons Redevelopment Authority (FRA) opens its new $8 million Accelerator facility today, expanding its Bioscience Park Center (BPC) by roughly 50% with this state-of-the-art 37,000-square-foot structure.

By Media Moguls PR
FG Global is seeking participants for a depression study in over 25 cities in the United States.

By AccessCR Pty Ltd
The 2012 Clinical Trials Honour Roll Australian “Most Nominated” Award winners will be presented with their Awards at the ARCS Annual Scientific Conference Dinner in Darling Harbour, Sydney on Wednesday 6th June.

By Helix Research Center Ltd
UK based MNC,Helix Research Center has launched a Global Campaign to Promote the Concept of ' Clinical Research Practices ' in ICH & Non ICH regions

By ASHA Public Relations, LLC
NBIA Disorders Association will join the National Organization for Rare Disorders in observing Rare Disease Day on Wed., Feb. 29 to focus attention on patients affected by rare diseases, like Neurodegeneration with Brain Iron Accumulation (NBIA)

By Partnership for Cures
The 2011 Patient Impact Initiative funded 4 Rediscovery Research projects to impact patients in the next 3 years through clinical trials that repurpose existing therapies to create new treatments for different diseases.

All Press Releases

By Xhale, Inc.
Xhale Awarded NIH/NIMH SBIR Grant for Monitoring Microbicide Gel Use

By Cures Within Reach
Cures Within Reach is pleased to name Illinois Governor Pat Quinn as honorary chair of the 2nd Bioscience Awards Midwest event on June 17, 2014, celebrating patient impact through science, philanthropy and business.

By Vattikuti Foundation
Transplant Project is the “First” to Use IDEAL* Research Standards to Protect Patients

By Cures Within Reach
Cures Within Reach (Cures), a non-profit dedicated to medical repurposing research, will be represented by Dr. Bruce Bloom and Dr. E. Mitchell Seymour on the Editorial Board of a new journal entitled “Drug Repurposing, Rescue, and Repositioning."

By Cures Within Reach
Cures Within Reach is pleased to announce that Dr. Norbert G. Riedel will receive its Patient Impact Legacy Award at its Midwest BioScience Industry Gala on the evening of June 17th, 2014, in downtown Chicago.

By Expertscape
Leading Experts and Institutions Identified and Ranked Using Expertscape’s Objective, Data-Driven Health Analytic Website

By St. Lawrence University
Findings recently published in leading scientific journal "ACS Nano"

By Arrowhead Publishers
The 4th Annual Traumatic Brain Injury is pleased to announce that Andrew Maas, MD, Ph.D., Professor and Chairman at Antwerp University Hospital and University of Antwerp will return for the 2014 conference.

By Cures Within Reach
Cures Within Reach is partnering with BioMotiv to drive repurposing research toward patient impact, with initial focus on therapies for Lung Cancer.

By Cures Within Reach
The innovative medical research philanthropy Cures Within Reach has announced a marketing partnership with PatientsLikeMe to work together to improve patient lives.

By Discovery Clinical Trials
San Antonio Company Ranks 206th Among Nation’s Health Companies on 2013 List

By Cures Within Reach
Cures Within Reach is supporting research at Rush University Medical Center to accumulate data supporting a repurposed device for the treatment of Multiple Sclerosis as it seeks FDA-approval.

By Cures Within Reach
Batten Disease is a fatal, rare genetic disease affecting the nervous system and most often affecting children. Two families in the Chicago area touched by Batten are making a big difference in research through funds raised by their organizations.

By Burke Medical Research Institute
Ava Weibman won a $4,000 Summer Student Fellowship from the Parkinson’s Disease Foundation (PDF) and a 10-week laboratory experience in Burke Medical Research Institute’s Laboratory for Neuronal Specification.

By Cures Within Reach
On Monday, June 24th, 24 Golfers played over 1000 holes of golf at Ravinia Green Country Club to fund research into an immediately usable treatment for autism through Chicago’s philanthropic organization, Cures Within Reach.

By Cures Within Reach
On Monday, June 24th, Golfers will swing their way through 1400 holes of golf at Ravinia Green Country Club to fund research into an immediately usable treatment for autism through Chicago's philanthropic organization, Cures Within Reach.

By Cures Within Reach
Some of the most prominent leaders in bioscience and related industries will gather at the Standard Club in Chicago on Thursday, June 13, to celebrate the growth of the bioscience industry in the Midwest.

By Cures Within Reach
Understanding Drug Development will be the second webcast in the RARE Webinar Series providing relevant information to patients and caregivers battling rare diseases, which are defined as diseases that affect fewer than 200,000 people in the US and...

By The Jon Block Group
The Jon Block Group announced they will be participating in the 2013 annual meeting of the American Academy of Orthopaedic Surgeons, taking place in Chicago from March 19-23, 2013.

By Kalorama Information
One of the victims the automatic federal sequestration budget cuts could be the 1.6 billion DNA sequencing market, according to Kalorama Information.

By Cures Within Reach
Each year the designation of the final day of February as Rare Disease Day generates increased awareness of the 7,000-plus rare disorders and fuels a greater urgency to develop more treatments for rare disease patients.

By Regional Feed
Medical researchers have this week claimed to have finally harnessed the health secret of the Mediterranean diet - in a SINGLE PILL.

By Discovery Clinical Trials
South Texas Native Moves Up from Vice President to COO of Discovery Clinical Trials and Synergyst Research Group

By Elite Research, LLC
Elite Research Describes Its Free Review for Medical Editing. Elite Research supports academic, corporate, medical/health, and nonprofit researchers in designing, collecting, analysing, and reporting efficient and accurate results.

By The Jon Block Group
Dr. Larry Miller, a Senior Associate at the The Jon Block Group, has accepted an invitation by SPINE Journal to join their Advisory Board.

By Elite Research LLC
Elite Research Explains How to Find Grants for Medical Research. Elite Research is a global provider of research design and statistical consulting. Elite Research supports nonprofits in design, collection, analysis, and reporting efficient results.

By Elite Research, LLC
Elite Research discusses helpful tips for collaborative research. Elite Research supports academic, corporate, medical/health, and nonprofit researchers in designing, collecting, analysing, and reporting efficient and accurate results.

By Uniting Against Lung Cancer
$200,000 Research Grant to Accelerate Benefit for Lung Cancer Patients

By Elite Research, LLC
Elite Research reveals three key strategies for publishing medical research. Elite Research supports academic, corporate, medical/health, and non-profit researchers in designing, collecting, analysing, and reporting efficient and accurate results.

By Absolutely PR
Fitzsimons Redevelopment Authority (FRA) opens its new $8 million Accelerator facility today, expanding its Bioscience Park Center (BPC) by roughly 50% with this state-of-the-art 37,000-square-foot structure.

By Angel Medical Systems
The Cardiovascular Institute of UMDNJ - Robert Wood Johnson University Hospital Announces ALERTS Pivotal Study for Implantable Cardiac Monitor and Alert System.

By Fathers Press
The Randomness of Life tells a compassionate story of heroes and their families who deal with neurological disorders.

By Media Moguls PR
FG Global is recruiting for a paid depression study that may be an alternative to traditional treatments for those who are unemployed and uninsured.

By Media Moguls PR
FG Global is seeking participants for a depression study in over 25 cities in the United States.

By AccessCR Pty Ltd
The 2012 Clinical Trials Honour Roll Australian “Most Nominated” Award winners will be presented with their Awards at the ARCS Annual Scientific Conference Dinner in Darling Harbour, Sydney on Wednesday 6th June.

By Partnership for Cures
On June 25th, 24 players will swing their way through 1400 holes of golf at Green Acres Country Club to raise $60,000 for research into new treatments for pediatric brain tumors through Chicago’s philanthropic organization, Partnership for Cures.

By Partnership for Cures
Noah’s Hope, housed under Partnership for Cures, recently received a 10k grant from the Tellabs Foundation. The funds support research defining biomarkers within the LINCL Batten Disease progression, a rare and deadly genetic pediatric disease.

By Angel Medical Systems
NEWARK – Saint Michael's Medical Center announces its first implant of a medical device designed to alert patients of an impending heart attack so they can seek medical attention and potentially avert damage to their heart, or even death.

By Helix Research Center Ltd
UK based MNC,Helix Research Center has launched a Global Campaign to Promote the Concept of ' Clinical Research Practices ' in ICH & Non ICH regions

By Better Health Publishing
Third study to show formula’s effectiveness also demonstrates no toxic side-effects

By ETCCR
East Tennessee Center for Clinical Research has a team that is dedicated to the highest performance standards of conducting clinical research studies while maintaining a high level of care for subjects.

By Uniting Against Lung Cancer
Uniting Against Lung Cancer (UALC) has committed over $1 million to support groundbreaking, innovative lung cancer research this year, bringing its total funding for lung cancer research to over $8.5 million since 2003.

By Better Health Publishing
Isaac Eliaz, M.D., M.S., L.Ac., distinguished medical doctor and researcher, presents Galectin-3 as a breakthrough biomarker for numerous life-threatening diseases.

By ASHA Public Relations, LLC
NBIA Disorders Association will join the National Organization for Rare Disorders in observing Rare Disease Day on Wed., Feb. 29 to focus attention on patients affected by rare diseases, like Neurodegeneration with Brain Iron Accumulation (NBIA)

By Partnership for Cures
The 2011 Patient Impact Initiative funded 4 Rediscovery Research projects to impact patients in the next 3 years through clinical trials that repurpose existing therapies to create new treatments for different diseases.

By MedTech
MedTech members are working with clinical researchers from medical universities, including The University at Buffalo, to address unmet or under-met healthcare needs. The most recent discussion, hosted by Greatbatch Medical, centered on cardiology.

By Better Health Publishing
Isaac Eliaz, M.D., M.S., L.Ac., distinguished medical doctor and leading Modified Citrus Pectin expert, gives a keynote presentation on Galectin-3 as a breakthrough biomarker for numerous life-threatening diseases.

By Allwrite Advertising
Dunwoody Wellness Center exceeded expectations when its 5K team raised the most money for the Winship Cancer Institute of Emory University.

By Better Health Publishing
Isaac Eliaz, M.D., M.S., L.Ac., world-renowned medical doctor, offers a presentation on the critical role of Modified Citrus Pectin (MCP) and Polybotanicals in Integrative Cancer Breakthroughs.

By Medscientist
Two final year MBBS students, Chetan Mandelia and Yashasvi Chugh of KMC, Mangalore won accolades for their presentations at the 18th International Student Congress of Medical Sciences (ISCOMS) at UMCG, Groningen, Netherlands from June 7 to 10, 2011



Page:

Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share